Post-market clinical evidence and regulatory documents for medical device manufacturers
We collect your PMCF data on our platform and deliver the PMCF report, PSUR and CER update with qualified partner medical writers, in one engagement.

Under EU MDR, certified devices in classes IIa, IIb and III carry recurring post-market obligations: periodic safety update reports, a PMCF plan and evaluation report, and clinical evaluation updates. The MDR transition deadlines for legacy devices fall on 31 December 2027 and 31 December 2028.
We offer data collection and document writing in one engagement. The clinical data is collected on the Vitruvian Shield platform. The regulatory documents are written by qualified partner medical writers under our quality oversight.
PMCF evidence collection on the platform
Post-market clinical data from patients and clinicians, in one dataset.
PMCF surveys
Structured surveys for patients and users of the device, scheduled and sent from the platform.
Patient-reported outcomes
Questionnaires completed on the patient's own phone, with reminders.
Clinician follow-up
Follow-up data entered by the treating clinician in electronic case report forms.
Electronic consent
Consent given and signed remotely, with a record from first view to signature.
One dataset with a full audit trail
Every record shows who entered it, when, and what changed.
Exports for the PMCF evaluation report
The dataset is exported ready for the medical writers who prepare the report.
Regulatory post-market documents
Written by qualified partner medical writers with EU medical device experience, under Vitruvian Shield's contract and quality oversight.
Periodic safety update report (PSUR)
The periodic summary of post-market surveillance data and conclusions for the device.
PMCF plan and PMCF evaluation report
The plan for post-market clinical follow-up, and the report that evaluates the data collected under it.
Clinical evaluation plan and clinical evaluation report update (CEP and CER)
The clinical evaluation plan, and the update of the clinical evaluation report with new post-market data.
Systematic literature search and review
Literature search and review supporting the PSUR, the PMCF evaluation report and the CER.
Clinical investigation documents
For device studies earlier in the device lifecycle. The investigation itself can then run on our platform, with eConsent, ePRO and EDC.
Clinical investigation application dossier
The technical and clinical parts of the application.
Investigator's brochure
The clinical and non-clinical information on the investigational device for the investigators.
Clinical investigation plan (protocol)
Written in collaboration with the sponsor and the investigating clinicians.
Prepared by qualified partner medical writers under our quality oversight; protocols are developed together with the sponsor and the investigators.
Timeframe defined in the written proposal after scoping.
The evidence-to-report package
One annual cycle per device family.
Data collected on the platform
PMCF surveys, patient-reported outcomes and clinician follow-up for the device family.
PMCF evaluation report
The collected data feeds the PMCF evaluation report.
PSUR and CER update
The PMCF evaluation report feeds the PSUR and the update of the clinical evaluation report.
Who it is for
Heads of regulatory affairs, quality and clinical affairs at medical device manufacturers in the EU, Switzerland and the United Kingdom. CE certificates are recognised in Great Britain.
Manufacturers from other countries, including the United States, that are preparing EU market entry.
Indicative timeframes
| Document | Indicative timeframe |
|---|---|
| Periodic safety update report (PSUR) | Delivery within 4 weeks of receiving complete input data |
| PMCF evaluation report | Delivery within 4 weeks of receiving complete PMCF data |
| CEP and CER update | Delivery within 4 to 6 weeks of receiving complete input data |
| Written proposal | Within one week of the scoping call |
Indicative timeframes from receipt of complete inputs; confirmed in the written proposal after scoping.
Start with a scoping call
Thirty minutes on your device family and your post-market obligations. A written proposal follows within one week of the call.